| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |




From the Department of Pathology,*
University of
Michigan Hospitals, Ann Arbor, Michigan; the Departments of Pathology
and Laboratory Medicine
and Pulmonary
Medicine,
Veterans Affairs Medical Center,
Ann Arbor, Michigan; and the Childrens
Hospital,§
Harvard Medical School,
Boston, Massachusetts
Mice with targeted mutation of chemokine receptor 1 (CCR1) were
used to assess the contribution of CCR1 agonists to local,
regional, and systemic inflammatory-related events during
experimental pulmonary granuloma formation. Models of Th1 (type-1) and
Th2 (type-2) cell-mediated lung granulomas were induced in wild-type
(CCR+/+) and knockout (CCR1-/-) mice by embolizing Sepharose beads
coupled to the purified protein derivative of Mycobacterium
bovis or soluble antigens derived from Schistosoma
mansoni eggs. Morphometric analysis indicated that granuloma
sizes were unchanged in CCR1-/- mice, but flow cytometric
analyses of dispersed granulomas revealed that natural killer cell
recruitment to type-1 lesions was abrogated by 60%. Analysis of
cytokine production by draining lymph node cultures showed altered
expression in CCR1-/- mice characterized by reduced interleukin-2 and
interferon-
in the type-1 response, and enhanced
interleukin-5 and interleukin-13 in the type-2 response. Peripheral
blood leukocytosis was also enhanced in the type-1 but not the type-2
response. These findings suggest that CCR1 agonists contribute to
multiple immunoinflammatory events in the type-1 granulomatous response
with natural killer cell accumulation being particularly sensitive to
CCR1 disruption. Although functional efficacy of granulomas may be
altered, chemokine redundancy and cytokine reserve seem to make
the bulk of the exudative response resistant to CCR1
disruption.
This article has been cited by other articles:
![]() |
G. Bernardini, G. Sciume, D. Bosisio, S. Morrone, S. Sozzani, and A. Santoni CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets Blood, April 1, 2008; 111(7): 3626 - 3634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Schaller, L. E. Kallal, and N. W. Lukacs A Key Role for CC Chemokine Receptor 1 in T-Cell-Mediated Respiratory Inflammation Am. J. Pathol., February 1, 2008; 172(2): 386 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mayer, K. L. Hudkins, F. Heller, H. Schmid, M. Kretzler, U. Brandt, H.-J. Anders, H. Regele, P. J. Nelson, C. E. Alpers, et al. Expression of the chemokine receptor CCR1 in human renal allografts Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1720 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wald, I. D. Weiss, H. Wald, H. Shoham, Y. Bar-Shavit, K. Beider, E. Galun, L. Weiss, L. Flaishon, I. Shachar, et al. IFN-{gamma} Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs. J. Immunol., April 15, 2006; 176(8): 4716 - 4729. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hanna, H. Mussaffi, G. Steuer, S. Hanna, M. Deeb, H. Blau, T. I. Arnon, N. Weizman, and O. Mandelboim Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency Blood, November 15, 2005; 106(10): 3465 - 3473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. S. Souza, E. Roffe, V. Pinho, D. G. Souza, A. F. Silva, R. C. Russo, R. Guabiraba, C. A. J. Pereira, F. M. Carvalho, M. M. Barsante, et al. Potential Role of the Chemokine Macrophage Inflammatory Protein 1{alpha} in Human and Experimental Schistosomiasis Infect. Immun., April 1, 2005; 73(4): 2515 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, S. Inan, A. Cowan, R. Sun, J. M. Wang, T. J. Rogers, M. Caterina, and J. J. Oppenheim A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1 PNAS, March 22, 2005; 102(12): 4536 - 4541. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Ness, K. J. Carpenter, J. L. Ewing, C. J. Gerard, C. M. Hogaboam, and S. L. Kunkel CCR1 and CC Chemokine Ligand 5 Interactions Exacerbate Innate Immune Responses during Sepsis J. Immunol., December 1, 2004; 173(11): 6938 - 6948. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Chiu, C. M. Freeman, V. R. Stolberg, J. S. Hu, K. Zeibecoglou, B. Lu, C. Gerard, I. F. Charo, S. A. Lira, and S. W. Chensue Impaired Lung Dendritic Cell Activation in CCR2 Knockout Mice Am. J. Pathol., October 1, 2004; 165(4): 1199 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang and L. D. Hazlett Analysis of Pseudomonas aeruginosa Corneal Infection Using an Oligonucleotide Microarray Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3409 - 3416. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Maghazachi G protein-coupled receptors in natural killer cells J. Leukoc. Biol., July 1, 2003; 74(1): 16 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ajuebor, C. M. Hogaboam, T. Le, and M. G. Swain C-C Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Directly Inhibits NKT Cell IL-4 Production and Is Hepatoprotective in T Cell-Mediated Hepatitis in the Mouse J. Immunol., May 15, 2003; 170(10): 5252 - 5259. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Scott and J. L. Flynn Mycobacterium tuberculosis in Chemokine Receptor 2-Deficient Mice: Influence of Dose on Disease Progression Infect. Immun., November 1, 2002; 70(11): 5946 - 5954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Heydtmann and D H Adams Understanding selective trafficking of lymphocyte subsets Gut, February 1, 2002; 50(2): 150 - 152. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |